Healthcare Global Enterprises

Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning

Alexandre Boutet, Radhika Madhavan, Gavin J.B. Elias et al. · Nature Communications · 2021 · 276 citations · Full text

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text

Efficacy of lycopene in the management of oral submucous fibrosis

Abhinav Kumar, Anjana Bagewadi, Vaishali Keluskar et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 2006 · 177 citations

Allergy, Oral Cavity, Oral Submucous Fibrosis +2

Review—Electrochemistry and Other Emerging Technologies for Continuous Glucose Monitoring Devices

Saroj Kumar Das, Kavya K. Nayak, P. R. Krishnaswamy et al. · ECS Sensors Plus · 2022 · 141 citations · Full text

Chemical Engineering, Biomedical Sensors, Medical Monitoring +14

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

Amanda Psyrri, Jérôme Fayette, Kevin J. Harrington et al. · Annals of Oncology · 2022 · 133 citations · Full text